Evidence map›Paper›PMID 11127261›Full record

ReviewJournal of clinical pathology2000

ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

D Gaffney, G S Fell, D S O'Reilly

Abstract readReview
In one paragraph

Review in Journal of clinical pathology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Current Management of Neurological Wilson's Disease.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025
    Review
  2. Article
  3. Unilateral K-F ring in Wilson's disease.GMS ophthalmology cases · 2023
    Article
  4. A review and current perspective on Wilson disease.Journal of clinical and experimental hepatology · 2013
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Copper:caeruloplasmin ratio.Journal of clinical pathology · 2007
    Article
  10. Article
  11. Electronic publishing and internet learning.Journal of clinical pathology · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

D GaffneyDepartment of Biochemistry, Royal Infirmary, Castle Street, Glasgow G4 OSF, UK.
G S Fell
D S O'Reilly

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease, the most common inherited disorder of copper metabolism, is a recessive genetic condition. The clinical presentation of Wilson's disease is very variable. It is characterised by low serum copper and caeruloplasmin concentrations coupled with the pathological accumulation of copper in the tissues. However, there are diagnostic difficulties and these are discussed. The current value of DNA diagnosis, both in gene tracking in families or as applied to de novo cases, is examined. Wilson's disease can be treated successfully but treatment must be life long. Patients are best treated by specialist centres with experience and expertise in the condition.

Indexed as

BiomarkersCopperHepatolenticular DegenerationHumansMutationBiomarkersCopper

Identifiers

PMID11127261
PMCPMC1731102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.